Chantasrisawad N, Techasaensiri C, Kosalaraksa P, Phongsamart W, et al. The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial. Int J Infect Dis 2023 Feb 23:S1201-9712(23)00066.
PMID: 36841501